Hypertension at time of diagnosis and long-term outcome after childhood ischemic stroke
Lauren N Brush, Paul T Monagle, Mark T Mackay, Anne L Gordon
Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2013
L. Brush reports no disclosures. M. Mackay received research funding from the Murdoch Children's Research Institute, the Brain Foundation, and the National Stroke Foundation. P. Monagle received research funding from the National Health and Medical Research Council of Australia, the Brockoff Foundation, Royal Children's Hospital Foundation Melbourne, University of Melbourne, Murdoch Children's Research Institute, and Bayer. He is a member of the steering committee of the Bayer-sponsored trial of rivaroxaban in children, and has given talks at a Stago-sponsored symposium. He gave evidence as an expert witness in the trial Waller v James. A. Gordon received research funding from the Murdoch Children's Research Institute. Go to Neurology.org for full disclosures.